ClinConnect ClinConnect Logo
Search / Trial NCT07023406

Effectiveness of and Implementation Strategies for 'Disfrutando'.

Launched by UNIVERSITY OF MISSOURI-COLUMBIA · Jun 10, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Participatory Research T2 Dm High Burden Populations

ClinConnect Summary

This clinical trial is testing a program called "Disfrutando" designed to help people prevent and manage type 2 diabetes, a common condition that affects how your body controls blood sugar. The study focuses on not only teaching people about managing their diabetes but also addressing social challenges—like access to healthy food or safe places to exercise—that can make it harder to stay healthy. The goal is to find practical ways to support people living with or at risk for type 2 diabetes.

To take part, individuals need to be between 65 and 74 years old and have a blood test called Hemoglobin A1C at 5.7 or higher, which shows higher blood sugar levels and a risk for diabetes. People with lower blood sugar levels (A1C of 5.6 or less) cannot join. While the study is not recruiting yet, participants can expect to engage with the "Disfrutando" program, which aims to help them improve their health by learning self-care skills and overcoming everyday barriers to healthy living. This trial includes men and women and hopes to make managing diabetes easier and more effective for those involved.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Hemoglobin A1C of 5.7 or higher
  • Exclusion Criteria:
  • Hemoglobin A1C of 5.6 or lower

About University Of Missouri Columbia

The University of Missouri-Columbia is a leading academic institution dedicated to advancing medical research and clinical innovation. As a prominent sponsor of clinical trials, the university leverages its extensive resources and expertise to facilitate groundbreaking studies aimed at improving patient outcomes across a variety of health conditions. With a commitment to ethical research practices and collaboration with multidisciplinary teams, the University of Missouri-Columbia strives to translate scientific discoveries into effective therapeutic interventions, ultimately enhancing the quality of care in the communities it serves.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported